Gold’s bull run has been explosive. Prices have surged over the past year as investors piled into safe havens, dragging ASX gold shares higher.

But not all gold names are created equal — and none exemplify that better than Ramelius Resources Ltd (ASX: RMS) and Meeka Metals Ltd (ASX: MEK).

Ramelius Resources shares have soared 81% over the past 12 months and Meeka a whopping 119%, while the gold commodity price rose 68%.

Let’s have a look at whether the ASX gold shares could keep the pace going.

Ramelius Resources Ltd (ASX: RMS)

This ASX gold share has been one of the quieter winners of the gold rally, with its share price powering higher over the past year as higher bullion prices collided with improving operational delivery.

As a profitable mid-tier producer with multiple Western Australian assets, Ramelius has benefited from rising margins, strong cash generation, and growing confidence that its production base is sustainable rather than short-lived. Investors have rewarded that stability, pushing the ASX gold stock ahead of many peers still grappling with cost blowouts or development risks.

The big strength for Ramelius is execution. It is already producing, already generating cash, and already reinvesting into exploration and extensions that could support output for years. That lowers risk and gives the company leverage to gold prices without the existential threats facing smaller miners.

The flip side is that expectations are now higher. Costs remain elevated across the sector, and any slip in grades, mine sequencing, or gold prices could quickly cool enthusiasm.

Analysts generally see further upside for the ASX gold share, but most are more measured than the market was six months ago. After the miner revealed its 2Q FY26 results, Morgans maintained its buy rating on the stock and lifted its price target from $4.50 to $5.50.

That points to a 23% upside, compared to the share price of $4.47 at the time of writing.

Meeka Metals Ltd (ASX: MEK)

This smaller ASX gold share has delivered the kind of share price surge that gold investors dream about. As sentiment around the gold sector heated up, Meeka’s transition from explorer to emerging producer lit a fire under the stock, sending it almost 120% higher over the past year.

Unlike Ramelius, Meeka’s gains have been driven less by current cash flow and more by what investors believe the company could become if its Murchison project delivers as planned.

That optionality is Meeka’s greatest strength. A growing resource base, improving project economics, and a clear pathway toward production give the company significant leverage to a strong gold price. If execution goes smoothly, the ASX gold stock could continue to outpace both gold and much of the sector.

But that leverage cuts both ways. The company remains small, capital-hungry, and highly sensitive to delays, cost overruns, or weaker sentiment. Any stumble could hit the share price hard.

Analyst coverage is limited but optimistic, reflecting the upside potential rather than proven delivery. The average 12-month price target is $0.45, representing a potential gain of 97% from the current share price of $0.23.

Foolish Takeaway

Looking ahead, Ramelius offers steadier, production-led gains with lower risk. Meeka has greater upside, but only if it executes cleanly.

Big returns favour Meeka; more reliable exposure to gold favours Ramelius — both with risks as gold optimism runs high.

The post Can these 2 ASX gold shares keep outpacing the gold rally? appeared first on The Motley Fool Australia.

More reading

• 3 ASX mining shares to buy: Morgans
• 5 things to watch on the ASX 200 on Tuesday
• Morgans names 3 exciting small cap ASX stocks to buy now
• Ramelius Resources shares: December 2025 quarterly earnings highlights
• 2 ASX 200 gold stocks making moves on big news today

Motley Fool contributor Marc Van Dinther has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

On Tuesday, the Reserve Bank of Australia lifted the cash rate by 25 basis points to 3.85%.

That move is likely to translate into slightly higher returns on savings accounts and term deposits in the months ahead. But even with rates moving higher, income investors are not short of alternatives.

In fact, the ASX still offers dividend yields that comfortably beat bank interest rates, with the added bonus of potential capital growth over time.

With that in mind, here are three ASX dividend shares that could still be worth considering for income-focused investors.

Centuria Industrial REIT (ASX: CIP)

The first ASX dividend share that could beat bank interest rates is Centuria Industrial REIT.

It owns a diversified portfolio of industrial properties, including warehouses, logistics facilities, and distribution centres leased to a broad range of tenants. These assets tend to benefit from long lease terms and rental increases that help support predictable income.

While higher interest rates have weighed on the broader REIT sector, industrial property fundamentals have remained relatively resilient. Demand for well-located logistics and warehousing space continues to be underpinned by e-commerce and supply chain investment.

Bell Potter is bullish on the company. It has a buy rating and $3.75 price target on its shares.

As for income, the broker is forecasting payouts of 16.8 cents per share in FY 2026 and 17.3 cents per share in FY 2027. Based on its current share price of $3.21, this would mean dividend yields of 5.2% and 5.4%, respectively.

Harvey Norman Holdings Ltd (ASX: HVN)

Another ASX dividend share that still stands out is Harvey Norman.

This retail giant operates across furniture, electronics, and homewares, and while discretionary spending has been under pressure, Harvey Norman’s business model provides some insulation. Its franchise structure, strong property backing, and net cash position give it flexibility through the cycle.

Even after the latest rate hike, its dividend potential remains well ahead of what most bank deposits can offer.

For example, Bell Potter, which has a buy rating and $8.30 price target on its shares, is expecting fully franked dividends of 30.9 cents per share in FY 2026 and then 35.3 cents per share in FY 2027.

Based on its current share price of $6.51, this would mean dividend yields of 4.8% and 5.4%, respectively.

Transurban Group (ASX: TCL)

A final ASX dividend share to consider is Transurban. It owns and operates toll roads across Australia and North America, generating revenue from long-dated infrastructure assets that are difficult to replicate.

Traffic volumes tend to grow over time with population and economic activity, providing a long runway for cash flow growth. Importantly, many of Transurban’s toll roads have built-in inflation-linked toll increases. This helps protect income even when inflation and interest rates are elevated.

Citi is a fan of the company and has put a buy rating and $16.10 price target on its shares.

With respect to dividends, the broker expects payouts of 69.5 cents per share in FY 2026 and then 73.7 cents per share in FY 2027. Based on its current share price of $13.88, this would mean dividend yields of 5% and 5.3%, respectively.

The post 3 ASX dividend shares that still beat bank interest rates appeared first on The Motley Fool Australia.

More reading

• 2 ASX blue-chip shares offering big dividend yields
• 2 ASX shares that are absurdly cheap right now
• Where I’d invest in ASX shares if the RBA increases the interest rate
• 3 high-yield ASX dividend shares that smash term deposits
• The smartest ASX dividend shares to buy with $1,000 right now

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Transurban Group. The Motley Fool Australia has positions in and has recommended Harvey Norman and Transurban Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The Amcor PLC (ASX: AMC) share price is in focus after the packaging giant posted a 68% rise in quarterly net sales to US$5.45 billion, thanks largely to the Berry acquisition. Adjusted EBITDA soared 83% from last year, reaching US$826 million.

What did Amcor report?

• Second quarter net sales of US$5,449 million, up 68% year-on-year
• Adjusted EBITDA of US$826 million, up 83% from a year ago
• Adjusted EBIT at US$603 million, a 66% increase
• Adjusted EPS of US$0.86, up 7%
• Free cash flow of US$289 million, after acquisition and restructuring costs of US$69 million
• Quarterly dividend declared at US$0.65 per share or 93.0 Australian cents unfranked for ASX investors

What else do investors need to know?

Amcor’s huge jump in sales and earnings comes off the back of its recent US$6.4 billion Berry Global acquisition, which added around US$2.2 billion in quarterly sales and delivered US$55 million in synergy benefits. Despite the integration costs, management reaffirmed full-year guidance, expecting adjusted EPS between US$4.00–$4.15, which would be 12%–17% growth on a constant currency basis.

The flexible and rigid packaging segments both saw significant improvement in margins and profit, even as underlying volumes were a touch softer. The board’s confidence is underlined by an increase in the quarterly dividend. Net debt rose to US$14.1 billion, reflecting acquisition funding, but cash flow is positive after accounting for integration costs.

What did Amcor management say?

Amcor CEO Peter Konieczny said:

Our Q2 financial performance was in line with expectations in a challenging volume environment. Strong Adjusted EPS growth was driven by disciplined execution and synergy benefits from the Berry acquisition at the upper end of expectations. Performance through the first half of the year supports our confidence in reaffirming fiscal 2026 earnings and free cash flow guidance. Portfolio optimization actions are progressing well, positioning us to be the global leader in consumer packaging and dispensing solutions for nutrition, health, beauty and wellness.

What’s next for Amcor?

Looking ahead, Amcor expects a full year of Berry Global contributions to support double-digit EPS growth and strong cash flow. The company is continuing with portfolio optimisation, targeting non-core divestments and efficiency gains from its expanded footprint.

Investors can expect management to focus on delivering US$260 million or more in annual synergies from the Berry deal. The team is also eyeing further initiatives to strengthen Amcor’s position as a global packaging leader.

Amcor share price snapshot

Over the past 12 months, Amcor shares have declined 20%, trailing the S&P/ASX 200 Index (ASX: XJO) which has risen 6% over the same period.

View Original Announcement

The post Amcor earnings: Net sales rocket 68% on Berry deal; guidance reaffirmed appeared first on The Motley Fool Australia.

More reading

• Abacus Storage King weighs management internalisation: What investors need to know
• 5 things to watch on the ASX 200 on Wednesday
• This ASX 200 defensive stock just hit a multi-year low. Buy the dip or stay away?
• Pinnacle Investment Management profit dips as revenue climbs, dividend steady
• 3 ASX 200 momentum stocks to buy right now

Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has positions in and has recommended Amcor Plc. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

The Abacus Storage King (ASX: ASK) share price is in focus today after the company announced it has started talks to potentially bring its management in-house. Key highlights include the formation of an independent board committee and early-stage discussions with Abacus Group.

What did Abacus Storage King report?

• The Board is considering internalising ASK’s management functions
• A Board sub-committee of independent directors has been formed
• Discussions between ASK and Abacus Group (ASX:ABG) have commenced
• Steven Sewell to remain MD of Abacus Group if internalisation proceeds
• Nikki Lawson slated to be CEO of Abacus Storage King if the deal is completed

What else do investors need to know?

Abacus Storage King emphasised that these discussions are at an early stage, and there is no guarantee that an internalisation transaction will proceed. Securityholders do not need to take any action for now.

To ensure the process is independent and transparent, the sub-committee of independent directors has appointed Macquarie Capital (Australia) Limited as its financial adviser and King & Wood Mallesons as legal adviser. The company has also committed to keep the market updated according to continuous disclosure requirements.

What’s next for Abacus Storage King?

The possible internalisation of management marks a significant potential shift in how Abacus Storage King is run. If the process goes ahead, it could lead to greater alignment between management and security holders, subject to final agreement and regulatory approval.

For now, investors will have to wait for any material developments, as ASK has committed to updating the market as discussions progress.

Abacus Storage King share price snapshot

Over the past 12 months, Abacus Storage Kin shares have risen 35%, outperforming the S&P/ASX 200 Index (ASX: XJO) which as risen 6% over the same period.

View Original Announcement

The post Abacus Storage King weighs management internalisation: What investors need to know appeared first on The Motley Fool Australia.

More reading

• Amcor earnings: Net sales rocket 68% on Berry deal; guidance reaffirmed
• How many Macquarie shares do I need to buy for $1,000 of annual passive income?
• 5 things to watch on the ASX 200 on Wednesday
• This ASX 200 defensive stock just hit a multi-year low. Buy the dip or stay away?
• Pinnacle Investment Management profit dips as revenue climbs, dividend steady

Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Macquarie Group. The Motley Fool Australia has positions in and has recommended Macquarie Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

Fortunately for income investors, there are a lot of options for them to choose from on the Australian share market.

But which ASX dividend stocks could be buys right now? Let’s take a look at three high-yield options that could be worth considering this month:

Accent Group Ltd (ASX: AX1)

The first ASX dividend stock that could be a buy for income investors is Accent Group.

It operates a portfolio of footwear brands across Australia and New Zealand, including Platypus, Skechers, and Hype.

As a discretionary retailer, it has felt the impact of cost-of-living pressures, which has weighed on earnings and investor sentiment. However, the business remains well managed, with a focus on inventory discipline, brand partnerships, and private-label growth. These factors help protect margins through tougher trading conditions.

While dividends may fluctuate in the near term, Accent Group has a track record of returning capital to shareholders when conditions allow. If consumer spending normalises over time, there is potential for both earnings and dividends to recover.

Accent’s shares are expected to provide dividend yields of ~6% and 8% in FY 2026 and FY 2027, respectively.

IPH Ltd (ASX: IPH)

IPH is another ASX dividend stock that could be a buy this month.

It provides intellectual property services such as patent and trademark filings across Australia, Asia, and North America. Its earnings are linked to long-term innovation trends rather than short-term economic cycles, although activity can slow during periods of uncertainty.

Recent softness in filing volumes has weighed on its share price, but the business continues to generate strong cash flows.

In light of this, the market is expecting fully franked dividend yields greater than 10% in both FY 2026 and FY 2027.

Premier Investments Ltd (ASX: PMV)

A third ASX dividend stock that could be a buy is Premier Investments.

It owns brands such as Smiggle and Peter Alexander and also holds a significant investment portfolio. Like other retailers, it has faced a tougher consumer environment, which has dampened near-term earnings expectations.

Despite this, Premier Investments has historically maintained a strong balance sheet and has shown a willingness to return excess capital to shareholders. In addition, its exposure to both retail operations and investments provides flexibility across the cycle.

If consumer confidence improves, Premier Investments has the operating leverage to deliver a rebound in profits and dividends.

In the meantime, the company’s shares are expected to provide ~6% and 6.6% dividend yields this year and next.

The post Meet the ASX dividend stocks offering massive 6% to 10% yields appeared first on The Motley Fool Australia.

More reading

• Aussie income stocks: A once-in-a-decade chance to get richer?
• Got $5,000? 5 ASX income shares to buy and hold forever
• 1 ASX dividend stock down 62% I’d buy right now
• $10,000 in these ASX dividend shares pays how much passive income?
• Here are the top 10 ASX 200 shares today

Motley Fool contributor James Mickleboro has positions in Accent Group. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Accent Group, IPH Ltd , and Premier Investments. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Owning Woodside Energy Group Ltd (ASX: WDS) shares usually means getting good passive income in terms of the dividend yield.

The company’s dividend can bounce around because it’s heavily linked to the level of profit that the ASX energy share can generate. Energy prices play a very important role.

Woodside’s production costs typically don’t change much year to year per unit of production. That means that any additional revenue for that production largely adds to the net profit line (after paying more to the government), while a decline in that revenue largely cuts into net profit.

I think it’s good to keep the above in mind when it comes to future dividend payments for owners of Woodside shares.

FY25

The company’s financial year follows the calendar year, so its FY25 has only recently finished. The ASX energy share recently released the 2025 fourth quarter update, giving brokers like UBS the chance to provide analysis on the company.

After seeing its production numbers and 2026 guidance, UBS said:

Woodside Energy (WDS) reported DQ25 production +4% & sales rev +7% ahead of market expectations due to stronger oil production from both Mad Dog (US Gulf Coast) & Sangomar (Senegal).

While Sangomar has started to decline from 4Q25, a beneficial one-off adjustment to WDS’ share of production under the production sharing contract with the Senegalese Gov saw higher q/q production net to WDS.

New 2025 line item guidance, combined with stronger 4Q production sees us lift 2025E EPS +8% and bolstering the 2025E final div (we assume a payout of 80% of underlying NPAT.

…While the FY[25] result is now substantially de-risked, we remain cautious of a material forecast decline y/y into 2026 on NPAT & divs & FCF [free cash flow].

UBS is predicting that the business could decide to pay a final dividend per share of US 39 cents per share with the FY25 result, with the annual payout being US 92 cents per share.

FY26

We’re already a month into the 2026 financial year for Woodside and UBS commented on the company’s 2026 guidance. It said:

Despite strong 4Q oil production, new 2026 production guidance was 4% below consensus expectations at the midpoint. Production guidance by product points to weaker oil production in 2026 than the market expected (LNG production was in line). We believe the key driver of an implied 13% cut to cons 2026 oil production forecasts (to meet midpoint of guidance) is a faster decline rate at Sangomar followed by natural field decline in Aust. oil assets.

UBS is projecting that Woodside could pay an annual dividend per share of US 43 cents in FY26.

FY27

The dividend payout per Woodside share is expected by UBS to increase in the 2027 financial year.

The ASX energy share is predicted to pay an annual dividend per share of US 67 cents in FY27.

FY28

The 2028 financial year could see the company’s annual dividend almost recover back to FY25 levels.

UBS’ forecast suggests that the business could pay an annual dividend per share of US 83 cents in FY28.

FY29

The last year of this series of projections is the 2029 financial year, which is quite a while away in the world of energy.

UBS forecasts that the business could pay an annual dividend per share of US 77 cents in FY29.

The post Here’s the dividend forecast out to 2029 for Woodside shares appeared first on The Motley Fool Australia.

More reading

• 3 ASX ETFs to target following the RBA interest rate hike
• 10 most traded ASX shares among 1 million Aussie investors last year
• Oil pulls back as markets look to the next catalyst. Here’s what to watch
• Buying ASX energy shares? Here’s how Santos and Woodside shares stacked up in January
• Here’s the earnings forecast out to 2028 for Woodside shares

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Experts are feeling very bullish about the prospects of certain ASX shares with numerous buy ratings.

I think it can be a very positive sign for potential positive returns when a business is rated as a buy by a number of analysts, rather just one or two.

Of course, it’s possible that they’re all wrong. But, I also have a positive view on the below ASX shares at the current valuations.

WiseTech Global Ltd (ASX: WTC)

According to CMC Markets, in the last three months there have been seven different analysts that have called WiseTech shares a buy. The global technology company provides software for the logistics sector.

The average price target for the WiseTech share price is $106.14, implying a possible rise of more than 80% within the next year. The most optimistic price target is $130, implying a theoretical rise of more than 120%, while the lowest price target of $74 still implies a possible rise of close to 30%.

While the market may be concerned about a possible impact by AI on the ASX share, UBS thinks that there’s an opportunity for names in the software as a service (SaaS) space to benefit from AI monetisation and deliver rising average revenue per user (ARPU).

UBS thinks that a new commercial model could drive price rises of around 5% going forwards, with customers benefiting from four new AI capabilities.

The broker thinks there could be further upside for WiseTech if “i) large freight forwarders in contract move earlier than expected to the commercial model; and ii) customers [are] willing and able to disburse/pass through their CargoWise software costs to the end customer”.

UBS thinks the WiseTech share price valuation is attractive as it’s trading cheaper than it has historically and it has AI defensiveness.

Lottery Corporation Ltd (ASX: TLC)

The national lottery operator has been rated as a buy by at least four brokers, according to CMC Markets.

The average price target on the business is $5.53, implying a potential mid-single-digit rise. The highest price target of $6.30 implies a theoretical rise of around 20% within the next year.

UBS is the broker that’s most optimistic about the ASX share. The broker wrote in a recent note:

We believe Lottery Corp has a compelling ‘growth formula’ that may be underestimated by [market] consensus forecasts. Once normalising for the jackpot cycle (now UBSe FY27E), we expect Lottery Corp to consistently deliver high single digit EPS growth supported by (1) GDP lottery top line (UBSe revenue +4.3% pa), (2) digital channel mix shift (UBSe VC +5.9% pa), (3) scalable cost base (UBSe EBITDA 6.6% pa), and (4) capital boosters such as leverage and buybacks (post Vic licence renewal). By FY31 we forecast EPS 6% higher than consensus, mostly due to digital mix/ VC margin.

A mixture of revenue growth, rising margins and share buybacks for investors could mean very positive things for owners of this ASX share.

UBS predicts earnings per share (EPS) could rise from a predicted 17 cents in FY26 to 26 cents in FY30, while maintaining a high dividend payout ratio.

The post 2 ASX shares highly recommended to buy: Experts appeared first on The Motley Fool Australia.

More reading

• Why I think the market is wrong about WiseTech shares
• These were the 10 most traded Australian shares last week
• 2 unloved ASX 200 shares I’m tipping to beat the market
• Down 50% from recent highs: Is it time to buy these ASX stocks?
• Why buy and hold investing with ASX shares could make you rich

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended The Lottery Corporation and WiseTech Global. The Motley Fool Australia has positions in and has recommended WiseTech Global. The Motley Fool Australia has recommended The Lottery Corporation. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

If you have $5,000 to invest this month, exchange traded funds (ETFs) could be worth considering.

They can make it easier to get diversified exposure to the share market without needing to pick individual winners.

By combining a small number of well-chosen ETFs, investors can gain access to global growth, high-quality businesses, and long-term structural themes, all in one simple portfolio. Here are three ASX ETFs that could be worth considering right now.

iShares S&P 500 AUD ETF (ASX: IVV)

The first ASX ETF to consider is the iShares S&P 500 AUD ETF.

This popular fund tracks the S&P 500 Index, giving investors exposure to many of the largest and most well-known businesses in the world. Current holdings include Apple (NASDAQ: AAPL), Microsoft (NASDAQ: MSFT), Amazon (NASDAQ: AMZN), and Costco Wholesale (NASDAQ: COST).

What makes this fund particularly compelling is the way the index evolves over time. This means that investors are not relying on today’s winners staying dominant forever, but instead they are backing the ongoing strength of the US corporate sector as a whole.

For long-term investors, the S&P 500 has been a powerful core holding over multiple decades.

VanEck Morningstar Wide Moat ETF (ASX: MOAT)

Another ASX ETF to consider is the VanEck Morningstar Wide Moat ETF.

This fund invests in US-listed companies that are judged to have sustainable competitive advantages, or wide economic moats. These are businesses that can defend their market positions over long periods through brand strength, switching costs, or scale.

Holdings include Adobe (NASDAQ: ADBE), Salesforce (NYSE: CRM), Airbnb (NASDAQ: ABNB), and Otis Worldwide (NYSE: OTIS). Each benefits from entrenched positions in their respective industries.

Rather than focusing on size or momentum, the VanEck Morningstar Wide Moat ETF looks for businesses trading at attractive prices relative to their long-term value. This quality-plus-valuation approach could appeal to investors who want growth potential without relying purely on optimism.

Betashares Global Cybersecurity ETF (ASX: HACK)

A final ASX ETF to look at is the Betashares Global Cybersecurity ETF.

It provides exposure to companies that protect digital systems, networks, and data. Its holdings include CrowdStrike (NASDAQ: CRWD), Palo Alto Networks (NASDAQ: PANW), Fortinet (NASDAQ: FTNT), and Zscaler (NASDAQ: ZS).

As businesses continue moving operations online and cyber threats become more sophisticated, demand for these services is likely to remain strong over the long term. This bodes well for the growth outlook of the fund’s holdings.

The post Where to invest $5,000 in ASX ETFs this month appeared first on The Motley Fool Australia.

More reading

• Should you consider currency-hedged ASX ETFs?
• 5 exciting ASX ETFs to buy this month
• Why I would buy and hold these VanEck ETFs for a decade or more
• 10 most popular ASX ETFs on the market today
• An easy and effective ASX portfolio with just 3 investments

Motley Fool contributor James Mickleboro has positions in VanEck Morningstar Wide Moat ETF. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended BetaShares Global Cybersecurity ETF and iShares S&P 500 ETF. The Motley Fool Australia has recommended VanEck Morningstar Wide Moat ETF and iShares S&P 500 ETF. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

During earnings season, it’s not uncommon to see large share price swings as investors react to results. Unfortunately for two ASX healthcare shares, recent announcements sent their share prices tumbling. 

Neuren Pharmaceuticals Ltd (ASX: NEU) and Clarity Pharmaceuticals Ltd (ASX: CU6) experienced share price declines yesterday of 10% and 4% respectively. 

Both ASX healthcare shares have had a tough past week. 

Does this create a buy low opportunity? Or is it going to be more of the same moving forward?

Let’s find out. 

Neuren Pharmaceuticals Ltd (ASX: NEU)

Neuren Pharmaceuticals is a biopharmaceutical company specialising in developing new therapies for neurodevelopmental disorders that emerge in early childhood and are characterised by impaired connections and signalling between brain cells.

Its share price crashed almost 10% yesterday after news was released that its partner, Acadia Pharmaceuticals Inc. (NASDAQ: ACAD), received a negative trend vote from Europe’s drug regulator for trofinetide, its treatment for Rett syndrome.

This dealt a potential blow to future revenue. 

While the drug is already approved in the US, Canada, and Israel, the uncertainty around European approval has investors selling, even though Acadia plans to appeal the decision.

For potential investors, the appeal process will certainly be worth monitoring, as it will directly impact future earnings. 

Its stock price is now down 15% in just the last 5 days of trading. 

Based on analyst ratings via TradingView, this could be a buy low opportunity for investors. 

Analysts ratings via TradingView have an average 12 month price target of $24.73 on this ASX healthcare stock. 

That indicates a massive upside of 69% from yesterday’s closing price of $14.63. 

However it doesn’t come without risk, pending the result of the company’s appeal. 

Clarity Pharmaceuticals Ltd (ASX: CU6)

This ASX healthcare stock has also been on the decline in the past week following the release of its quarterly report.

It is a clinical stage radiopharmaceutical company developing next-generation theranostic (therapy and imaging) products, based on its platform SAR Technology.

Clarity Pharmaceuticals shares fell 3.9% yesterday and are down more than 15% in the last week. 

After such a large fall in a short period of time, it could be a buy-low opportunity. 

This ASX healthcare stock closed trading yesterday at $2.96 per share. 

However the TradingView has an average analyst price target of $7.35. 

This indicates an upside of more than 148%. 

An important factor for future investors to monitor is the ongoing Phase II SECuRE clinical trial, which is testing a targeted treatment for advanced prostate cancer.

The post Are these 2 ASX healthcare shares a buying opportunity after yesterday’s crash? appeared first on The Motley Fool Australia.

More reading

• Why Brainchip, Credit Corp, Graincorp, and Neuren shares are falling today
• Guess which ASX 200 healthcare share is crashing 22% on Tuesday on European blow
• Neuren Pharmaceuticals revises DAYBUE revenue projections to reach US$700 million in 2028
• Top 3 ASX 200 healthcare shares in 2025
• Why 4DMedical, Amaero, Clarity Pharmaceuticals, and Treasury Wine shares are falling today

Motley Fool contributor Aaron Bell has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Here at The Motley Fool, we are always looking to identify S&P/ASX 200 Index (ASX: XJO) stocks that could be undervalued.

Three that have been hotly covered in recent weeks are Pro Medicus Ltd (ASX: PME), REA Group Ltd (ASX: REA) and Nextdc Ltd (ASX: NXT). 

These ASX 200 stocks are either sitting close to 52-week lows, or far from yearly highs.

However for all three, it looks like there could be greener pastures ahead. 

Based on recent price targets from analysts, let’s look at just how profitable they could be as a value investment over the next 12 months. 

Pro Medicus Ltd (ASX: PME)

Pro Medicus provides medical imaging technology globally. 

It is the ASX 200’s fifth-largest company.

The company is recognised as a leading supplier of radiology information systems (RIS), picture archiving and communication systems (PACS), and advanced visualisation solutions for medical practices and hospitals.

Yesterday, Pro Medicus shares closed at $177.56. 

This is a 37% drop over the last 12 months. 

However there is plenty of long-term potential for this ASX 200 stock. 

In its FY25 result, the company reported revenue growth of 31.9% to $213 million and net profit after tax (NPAT) growth of 39.2% to $115.2 million.

With strong fundamentals, low operating costs and a dominant market presence, I think it’s a matter of “when” not “if” this stock bounces back. 

A recent rating from Macquarie included an outperform rating and price target of $291.30. 

Should Pro Medicus shares hit this target in the next 12 months, a $10,000 investment would turn into approximately $16,409.

REA Group Ltd (ASX: REA)

REA Group shares have been heavily sold over the last year, likely due to AI concerns and competition worries.

But while investors have been exiting the stock, experts remain steadfast in their confidence. 

Yesterday, REA Group shares closed at $191.60 each. 

This is hovering close to yearly lows, with the ASX 200 stock down almost 23% in the last 12 months. 

The Motley Fool’s Tristan Harrison reported earlier this week that the team at UBS sees UBS an economic moat in customer experience, brand, uniqueness of product and complexity of the ecosystem. 

The broker also said the negative AI narrative could unwind over this year.

UBS has a price target of $255 on REA Group shares. 

If this ASX 200 stock were to hit that target in the next year, a $10,000 investment would grow to approximately $13,308. 

Nextdc Ltd (ASX: NXT)

This ASX 200 stock has also been hotly covered due to its perceived value and connection with the AI trend.

The company operates data centres in Australia, New Zealand and Southeast Asia. It focuses on co-location services to local and international organisations as well as interconnectivity between enterprises, global cloud, ICT providers, and telecommunication networks.

While it has fought back considerably from 52-week lows, estimates from brokers indicates the current price is still a value play. 

NextDC shares closed yesterday at $13.26 each. 

However, Ord Minnett has a buy recommendation and a $20.50 target price on this ASX 200 stock. 

If it hit that target in a year, a $10,000 investment would grow to be worth approximately $15,460. 

The post How much could a $10,000 investment in these ASX 200 stocks be worth if they hit 12 month targets? appeared first on The Motley Fool Australia.

More reading

• 3 ASX growth shares to buy before they rebound
• 3 ASX 200 large-cap healthcare shares just re-rated by experts
• Experts rate these 2 ASX growth shares as buys this month!
• Why these beaten-down ASX shares are worth a second look
• Why buy and hold investing with ASX shares could make you rich

Motley Fool contributor Aaron Bell has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has recommended Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.